ProBioGen and VarmX partner to advance second Factor X therapy candidate
Pfizer’s LITFULO clears two Phase 3 vitiligo trials paving way for global regulatory filings
EU nod to Pfizer-BioNTech’s updated COVID-19 vaccine targeting XFG variant
Bayer seeks China approval to expand finerenone use for non-diabetic chronic kidney disease
AbbVie’s RINVOQ wins EU approval as first systemic treatment for vitiligo
Novo Nordisk's Phase 3 ZEUS trial misses cardiovascular endpoint for Ziltivekimab
Indokem Q1 FY27 revenue grows 12%, PAT jumps 53% to Rs. 1.07 crore
Mankind Pharma Q1 FY27 revenue crosses Rs. 4,000 crore, PAT surges 29% to Rs. 574 crore
Concord Biotech Q1 FY27 PAT jumps 31% to Rs. 57.7 crore
SMS Pharma Q1 FY27 PAT rises 16% to Rs. 21.1 crore
The company's EBITDA stood at Rs. 4,417.7 crore, up 2.7% from the corresponding quarter last year, with an EBITDA margin of 28.9%
Subscribe To Our Newsletter & Stay Updated
Chasing Consistency: Centralizing operations data is the key to optimizing chemicals plants
Implementing a digital transformation in chemical operations to maximize profitability
The complexity of compliance
The Sprint to the Summit: Unlocking Lab Efficiency through Digital Transformation
The guiding role of fluidized and spouted bed technologies in particle building processes
